Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsBone and BonesAnemia, AplasticHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemiaTransplantation ChimeraCyclophosphamideBone Marrow PurgingLiver TransplantationHematopoietic Stem CellsBone Marrow DiseasesGraft SurvivalTissue DonorsBusulfanCombined Modality TherapyHistocompatibility TestingHistocompatibilityTreatment OutcomeBone Marrow ExaminationHematopoiesisTransplantation, IsogeneicRecurrenceBone Marrow NeoplasmsMice, Inbred C57BLLeukemia, Myeloid, AcuteKidney TransplantationRadiation ChimeraTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisHematologic NeoplasmsLymphoma, Non-HodgkinLeukemia, MyeloidImmunosuppressive AgentsRemission InductionGraft RejectionHepatic Veno-Occlusive DiseaseColony-Forming Units AssayChemotherapy, AdjuvantBone RemodelingStem Cell TransplantationGraft vs Host ReactionTransplantation ImmunologyAcute DiseaseImmunosuppressionLymphocyte DepletionDisease-Free SurvivalSurvival RateLeukocyte TransfusionMyelodysplastic SyndromesEtoposideT-LymphocytesHeart TransplantationChimeraHematologic DiseasesSevere Combined ImmunodeficiencyActuarial AnalysisCytarabineCarmustineFollow-Up StudiesHLA AntigensPrognosisGranulocyte Colony-Stimulating FactorCell DifferentiationRetrospective StudiesAntineoplastic AgentsPancytopeniaCyclosporineLymphocyte TransfusionLeukocyte CountLung TransplantationMelphalanBone DensitySpleenMultiple MyelomaFlow CytometryMethotrexateLymphomaNuclear FamilyMice, Inbred BALB CHodgkin DiseaseCells, CulturedGraft vs Tumor EffectOrgan TransplantationAntigens, CD34Graft vs Leukemia EffectCytomegalovirus InfectionsBone ResorptionFatal OutcomeDoxorubicinGranulocytes